← Alle mensen

AL

Anwen Liu

8 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Durvalumab Combined With Chemotherapy and SABR Therapy in Patiënten met Oligogemetastaseerd Non-small Cell Longkanker: A Multicenter Fase 2-Studie
Int J Radiation Oncology · 24 september 2025
Eerstelijns Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC:...
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-07
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously tr...
Lancet (London, England) · 7 juni 2025
Camrelizumab plus carboplatine-pemetrexed bij niet-plaveiselcel NSCLC: CameL fase III update
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2023-05
Sintilimab plus bevacizumab en chemotherapie bij EGFR-gemuteerd NSCLC: ORIENT-31
The Lancet. Oncology · 2022-09
Sugemalimab versus placebo na chemoradiatie bij lokaal gevorderd NSCLC: GEMSTONE-301
The Lancet. Oncology · 2022-02
Niraparib als onderhoud bij uitgebreid SCLC na chemotherapie: fase II
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2021-08
Neoadjuvante chemoradiatie met capecitabine-irinotecan bij rectumcarcinoom: fase III
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 december 2020